16 C
New York
Friday, May 17, 2024
HomeMarkets
Markets

Benzinga’s Top Upgrades, Downgrades For August 1, 2018

By Insider Scoop
0
36
psw-placeholder
psw-placeholder

Courtesy of Benzinga.

Top Upgrades

  • Analysts at Benchmark upgraded Huron Consulting Group Inc. (NASDAQ: HURN) from Hold to Buy. Huron Consulting shares rose 6.6 percent to $46.55 in pre-market trading.
  • Morgan Stanley upgraded Sarepta Therapeutics, Inc. (NASDAQ: SRPT) from Equal-Weight to Overweight. Sarepta shares rose 4.3 percent to $121.18 in pre-market trading.
  • Jefferies upgraded Dropbox, Inc. (NASDAQ: DBX) from Hold to Buy. Dropbox shares rose 2.73 percent to $27.50 in pre-market trading.
  • Sandler O’Neill upgraded Aflac Incorporated (NYSE: AFL) from Hold to Buy. Aflac shares rose 0.45 percent to close at $46.54 on Tuesday.
  • Craig-Hallum upgraded Synaptics Incorporated (NASDAQ: SYNA) from Hold to Buy. Synaptics shares fell 11.2 percent to $44.48 in pre-market trading.
  • RBC Capital upgraded Pandora Media, Inc. (NYSE: P) from Sector Perform to Outperform. Pandora shares rose 15 percent to $7.75 in pre-market trading.
  • Susquehanna upgraded Wolverine World Wide, Inc. (NYSE: WWW) from Neutral to Positive. Wolverine World Wide shares rose 0.63 percent to close at $35.38 on Tuesday.
  • Jefferies upgraded Papa John’s International, Inc. (NASDAQ: PZZA) from Hold to Buy. Papa John’s shares dropped 0.24 percent to close at $41.96 on Tuesday.
  • Bernstein upgraded Cognex Corporation (NASDAQ: CGNX) from Market Perform to Outperform. Cognex shares climbed 19.28 percent to close at $52.78 on Tuesday.
  • Deutsche Bank upgraded AutoZone, Inc. (NYSE: AZO) from Hold to Buy. AutoZone shares rose 1.01 percent to close at $705.53 on Tuesday.

Top Downgrades

  • JMP Securities downgraded Incyte Corporation (NASDAQ: INCY) from Outperform to Market Perform. Incyte shares fell 1.56 percent to $65.50 in pre-market trading.
  • BMO Capital downgraded Universal Health Services, Inc. (NYSE: UHS) from Outperform to Market Perform. Universal Health shares fell 1.7 percent to $120.00 in pre-market trading.
  • Morgan Stanley downgraded Cytokinetics, Incorporated (NASDAQ: CYTK) from Overweight to Equal-Weight. Cytokinetics shares declined 2.1 percent to $7.20 in pre-market trading.
  • Stifel Nicolaus downgraded NewLink Genetics Corporation (NASDAQ: NLNK) from Buy to Hold. NewLink Genetics shares fell 5.6 percent to $3.57 in pre-market trading.
  • Compass Point downgraded Horizon Technology Finance Corporation (NASDAQ: HRZN) from Neutral to Sell. Horizon Tech Finance shares fell 3.6 percent to $10.35 in pre-market trading.
  • RBC Capital downgraded Quotient Technology Inc. (NYSE: QUOT) from Outperform to Sector Perform. Quotient Technology shares rose 0.34 percent to close at $14.75 on Tuesday.
  • Deutsche Bank downgraded Akamai Technologies, Inc. (NASDAQ: AKAM) from Buy to Hold. Akamai shares fell 5.7 percent to $71.01 in pre-market trading.
  • BMO Capital downgraded Acadia Healthcare Company, Inc. (NASDAQ: ACHC) from Outperform to Market Perform. Acadia Healthcare shares dropped 8.4 percent to close at $39.48 on Tuesday.
  • Baird downgraded Canada Goose Holdings Inc. (NYSE: GOOS) from Outperform to Neutral. Canada Goose shares fell 2.8 percent to $55.80 in pre-market trading.
  • Citigroup downgraded Pearson plc (NYSE: PSO) from Buy to Neutral. Pearson shares fell 1.7 percent to $11.86 in pre-market trading.

Top Initiations

  • H.C. Wainwright initiated coverage on Kura Oncology, Inc. (NASDAQ: KURA) with a Buy rating. The price target for Kura Oncology is set to $31. Kura Oncology shares closed at $20.30 on Tuesday.
  • Stifel Nicolaus initiated coverage on Lilis Energy, Inc. (NYSE: LLEX) with a Buy rating. The price target for Lilis Energy is set to $12. Lilis Energy shares closed at $4.69 on Tuesday.
  • Roth Capital initiated coverage on Identiv Inc (NASDAQ: INVE) with a Buy rating. The price target for Identiv is set to $9. Identiv shares closed at $4.72 on Tuesday.
  • Jefferies initiated MarketAxess Holdings Inc. (NASDAQ: MKTX) with a Hold rating. The price target for MarketAxess is set to $219. MarketAxess shares closed at $193.77 on Tuesday.
  • Roth Capital initiated coverage on Sensus Healthcare Inc (NASDAQ: SRTS) with a Buy rating. The price target for Sensus Healthcare is set to $12.50. Sensus Healthcare shares closed at $6.82 on Tuesday.

Posted-In: Initiations top upgradesUpgrades Downgrades Initiation Pre-Market Outlook Analyst Ratings

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,204FansLike
396,312FollowersFollow
2,300SubscribersSubscribe

Latest Articles

Load more

Note: The material presented in this commentary is provided for informational purposes only and is based upon information that is considered to be reliable. However, neither PSW Investments, LLC d/b/a PhilStockWorld (PSW) nor its affiliates warrant its completeness, accuracy or adequacy and it should not be relied upon as such. Neither PSW nor its affiliates are responsible for any errors or omissions or for results obtained from the use of this information. Past performance, including the tracking of virtual trades and portfolios for educational purposes, is not necessarily indicative of future results. Neither Phil, Optrader, or anyone related to PSW is a registered financial adviser and they may hold positions in the stocks mentioned, which may change at any time without notice. Do not buy or sell based on anything that is written here, the risk of loss in trading is great.

This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities or other financial instruments mentioned in this material are not suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only intended at the moment of their issue as conditions quickly change. The information contained herein does not constitute advice on the tax consequences of making any particular investment decision. This material does not take into account your particular investment objectives, financial situations or needs and is not intended as a recommendation to you of any particular securities, financial instruments or strategies. Before investing, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

Contact us: support@philstockworld.com

© Copyright - PSW, LLC.

2024
0
Would love your thoughts, please comment.x
()
x